Hst Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 15, 2020 at 10:17 pm IST
Share
HST Global, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced operating loss was USD 34,818 compared to USD 36,308 a year ago. Net loss was USD 34,833 compared to USD 45,245 a year ago. Basic loss per share from continuing operations was USD 0.01.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
